Dr. Nick Haddad is a Professor in Integrative Biology at Michigan State University and a Senior Terrestrial Ecologist at the W.K. Kellogg Biological Station. In addition, Nick is the author of the recently released book The Last Butterflies: A Scientist’s Quest to Save a Rare and Vanishing Creature. Nick received his BS in Biology from Stanford University, and he was awarded his PhD in Ecology from the University of Georgia. Afterwards, Nick conducted postdoctoral research at the University of Minnesota. Before joining the faculty at Michigan State, University, Nick served on the faculty at North Carolina State University for about 19 years. In our interview, Nick shares more about his life and science.
Dr. David Berman is Head of Research and Development at Immunocore, a leading T cell receptor biotechnology company. He received his bachelor’s degree in biology from the Massachusetts Institute of Technology. Afterwards, David was awarded his PhD under the mentorship of Dr. Alfred Gilman (Nobel Prize 1994) and his MD from the University of Texas Southwestern Medical Center at Dallas. He completed his Residency in Anatomic Pathology at the National Cancer Institute and a Fellowship in Pathology at The Johns Hopkins University School of Medicine. David then began his 10-year tenure at Bristol-Myers Squibb, where he held various senior development roles in immuno-oncology. He then spent three years in immuno-oncology leadership positions at MedImmune and AstraZeneca. In our interview, David shares more about his life and science.
Dr. Lisa Whitenack is an Associate Professor in the Departments of Biology and Geology at Allegheny College. She received her B.S. in geology from the University of Illinois at Urbana-Champaign, her M.S. degree in geological sciences from Michigan State University, and her Ph.D. in integrative biology from the University of South Florida. Lisa served as an adjunct faculty member at the University of Tampa for about a year. She conducted postdoctoral research in geology at the University of South Florida before joining the faculty at Allegheny College. Lisa has been named Volunteer Partner of the Year by the Crawford County K-12 Career Education Alliance for her science outreach efforts. In our interview, Lisa shares more about her life and science.
Dr. Al Robichaud is Chief Scientific Officer at Sage Therapeutics, a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-altering central nervous system disorders. Al received his B.S. in chemistry from Rensselaer Polytechnic Institute. He worked as a staff chemist at FMC Corporation for about two years before returning to school to earn his PhD in Organic Chemistry from the University of California, Irvine. Al next conducted research as an American Cancer Society postdoctoral fellow in organic chemistry at Colorado State University. Before joining the team at Sage Therapeutics, Al held positions at Merck Pharma, DuPont Merck Pharma, DuPont Pharmaceuticals, Bristol-Myers Squibb, Wyeth Pharmaceuticals, and Lundbeck Research. In our interview, Al tells us more about his life and science.
Dr. Christine Drea is the Earl D. McLean Professor of Evolutionary Anthropology, as well as Professor in the Department of Biology, the University Program in Ecology, and the Duke Institute for Brain Sciences at Duke University. Christine completed her undergraduate training in zoology at the University of Maryland College Park. She earned her M.A. and Ph.D. degrees in psychobiology from Emory University. Afterwards, Christine conducted postdoctoral research in physiology at the Morehouse School of Medicine, and subsequently she was awarded a National Institutes of Health National Research Service Award postdoctoral fellowship in psychology to conduct research at the University of California, Berkeley. Next, Christine served as a lecturer at UC, Berkeley before joining the faculty at Duke University. At Duke, she has been awarded the Thomas Langford Lectureship Award for the appeal of her research to an interdisciplinary audience and her embodiment of Langford’s dedication to teaching, research, and service. In our interview, Christine shares more about her life and science.
Dr. Paul Cannon is the Parkinson’s Disease Program Manager at 23andMe. Paul received his Master’s degree in Natural Sciences from Christ’s College in Cambridge and his PhD in Medical Sciences from the University of Calgary. Afterwards, he worked as a Research Scientist at Syntex. Next, Paul spent nearly 15 years in various roles at Roche Pharmaceuticals and Genentech. He worked as a Senior Consultant for Tynan Consulting for about four years before joining the team at 23andMe. In our interview, Paul tells us more about his life and science.
Dr. Cori Richards-Zawacki is an Associate Professor in the Department of Biological Sciences and Director of the Pymatuning Lab of Ecology at the University of Pittsburgh. Cori received her Bachelor’s degree in engineering and biology as well as her PhD in ecology and evolutionary biology both from the University of Michigan. She conducted postdoctoral research at the Smithsonian Institute and the University of California, Berkeley. Cori next served on the faculty at Tulane University prior to joining the faculty at the University of Pittsburgh in 2015. In our interview, Cori shares more about her life and science.
Dr. Jim Doherty is Chief Research Officer at Sage Therapeutics, a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-altering central nervous system disorders. Jim received his B.A. in biology from the University of Delaware and his Ph.D. in neuroscience from Georgetown University. Next, he conducted postdoctoral research at Emory University Medical School and subsequently served on the faculty at Emory for about two years. Prior to joining the team at Sage in 2014, Jim worked for about eleven years at AstraZeneca Pharmaceuticals. In our interview Jim shares more about his life and science.
Dr. Neil Solomons is Chief Medical Officer and Co-Founder of Aurinia Pharmaceuticals, a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. Neil was awarded his Medical Degree from the University of London’s Guys Hospital Medical School. Afterwards, he worked as a physician in London and completed specialist training in anesthesia and intensive care. Neil held positions at Roche Pharmaceuticals, Aspreva Pharmaceuticals, and Vifor Pharma before co-founding Aurinia. In our interview Neil will tell us more about his life and science.
Dr. Anne Fung is the Global Development Lead for the Port Delivery System with Ranibizumab and Lucentis at Genentech. She is also a practicing retina specialist and researcher at Pacific Eye Associates and California Pacific Medical Center in San Francisco. Anne received her undergraduate degree from Wellesley College and her Medical Degree from Cornell University. She completed her residency in ophthalmology at Stanford University School of Medicine and then pursued a Medical Retina Fellowship at the Bascom Palmer Eye Institute and the University of Miami Miller School of Medicine. Anne worked in clinical practice for ten years before joining the team at Genentech in 2014. Anne is a Board Certified Ophthalmologist and is a Fellow of the American Academy of Ophthalmology. In our interview she shares more about her life and science.